Regen Lab Company

Regen Lab specializes in autologous platelet rich plasma (A-PRP®), prepared in a standardized fashion with RegenKit® Medical Devices, in addition to the combination of platelets with cells, such as adipose tissue and bone marrow concentrate. PRP therapy and PRP injections, alone and in combination with other cells, are the most widely used cell therapies in regenerative medicine. Furthermore, they have conceived a new vision for autologous tissue engineering: CellularMatrix™, a synergistic association of platelet rich plasma and hyaluronic acid.
Industry:
Gene Therapy
Headquarters:
Vaud
Estimated Revenue:
$1M to $10M
Register and Claim Ownership